EUVIMEDEUVIMED entdecken
KorrekturOpen Access

Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model

Curtis A Lachowiez, Joshua F Zeidner, Jad Othman, Andy Kaempf, Seongseok Yun, Maël Heiblig, Michael Heuser, Rabia Shahswar, Rafael Madero Marroquin, Joseph M Cannova, Andrius Žučenka, Jennifer Marvin-Peek und 39 weitere

Journal of Clinical Oncology · 20.08.2026 · 44 (24) · 2362-2362

DOI: 10.1200/jco-26-01801 ↗

Kurz gefasst

Korrektur in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.08.2026. Verfasst von Curtis A Lachowiez und 50 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lachowiez, C. A., Zeidner, J. F., Othman, J., Kaempf, A., Yun, S., Heiblig, M., Heuser, M., Shahswar, R., Marroquin, R. M., Cannova, J. M., Žučenka, A., Marvin-Peek, J., Senapati, J., Abaza, Y., Swaroop, A., Zacheo, I., Monaco, F., Belhabri, A., Tauveron-Jalenques, U., …, & PRISM-AML Investigators (2026). Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. Journal of Clinical Oncology, 44(24), 2362-2362. https://doi.org/10.1200/jco-26-01801

Vancouver

Lachowiez CA, Zeidner JF, Othman J, Kaempf A, Yun S, Heiblig M, et al. Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model. Journal of Clinical Oncology. 2026;44(24):2362-2362. doi:10.1200/jco-26-01801

BibTeX
@article{Lachowiez2026,
  author = {Lachowiez, Curtis A and Zeidner, Joshua F and Othman, Jad and Kaempf, Andy and Yun, Seongseok and Heiblig, Maël and Heuser, Michael and Shahswar, Rabia and Marroquin, Rafael Madero and Cannova, Joseph M and Žučenka, Andrius and Marvin-Peek, Jennifer and Senapati, Jayastu and Abaza, Yasmin and Swaroop, Alok and Zacheo, Irene and Monaco, Federica and Belhabri, Amine and Tauveron-Jalenques, Urbain and Tavernier, Emmanuelle and Carré, Martin and Requena, Gaspar Aspas and Cook, Rachel J and Traer, Elie and Saultz, Jennifer N and O'Nions, Jenny and Basheer, Faisal and Laurie, John and Handa, Shivani and Stein, Eytan M and Baer, Maria R and Olin, Rebecca and Blum, William and Schiller, Gary and Lin, Tara and Curran, Emily and Yocum, Ashley and Madarang, Ellen and Daver, Naval and Kadia, Tapan M and Marconi, Giovanni and Madanat, Yazan and Dillon, Richard and DiNardo, Courtney D and Swords, Ronan and Arango Ossa, Juan E and Watts, Justin and Loghavi, Sanam and Pollyea, Daniel A and Bernard, Elsa and PRISM-AML Investigators, PRISM-AML Investigators},
  title = {Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {24},
  pages = {2362--2362},
  doi = {10.1200/jco-26-01801}
}
Kostenlos starten →